Supriya Lifescience (BOM:543434) ROCE % : 26.68% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Supriya Lifescience ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Supriya Lifescience's annualized ROCE % for the quarter that ended in Sep. 2024 was 26.68%.

Supriya Lifescience ROCE % Historical Data

The historical data trend for Supriya Lifescience's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Supriya Lifescience ROCE % Chart

Supriya Lifescience Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

68.90

70.85

44.96

18.41

21.59

Supriya Lifescience Quarterly Data
	Mar19	Mar20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial													15.56	20.89	26.23	28.48	26.68

Supriya Lifescience ROCE % Calculation

Supriya Lifescience's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	1693.931	/	( ( (8202.77 - 957.8)	+	(9212.38 - 768.94) )	/ 2 )
	=	1693.931	/	( (7244.97	+	8443.44)	/ 2 )
	=	1693.931	/	7844.205
	=	21.59 %

Supriya Lifescience's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	2499.64	/	( ( (0 - 0)	+	(10123.91 - 754.4) )	/ 1 )
	=	2499.64	/	( ( 0	+	9369.51 )	/ 1 )
	=	2499.64	/	9369.51
	=	26.68 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Supriya Lifescience (BOM:543434) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Supriya Lifescience ROCE % Related Terms

Thank you for viewing the detailed overview of Supriya Lifescience's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Supriya Lifescience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Supriya Lifescience Ltd (BOM:543434) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

SUPRIYA:India

Address

Sonawala Road, 207/208, Udyog Bhavan, Goregaon East, Mumbai, MH, IND, 400063

Website

https://www.supriyalifescience.com

Supriya Lifescience Ltd is a manufacturer of Active pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.

Supriya Lifescience Headlines

No Headlines